Security key
05360L403
AVENUE THERAPEUTICS, INC. - Common Stock (ATXI)
CUSIP: 05360L403
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 192,628
- Total 13F value
- $385,256
- Share change
- -4,896
- SEC-reported price per share
- $2.00
- Number of holders
- 7
- Value change
- -$102,432
- Number of buys
- 5
- Number of sells
- 5
- Shares outstanding
- 3,190,732
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
7
Top holders
7
ATXI full security history
Ownership snapshot
Full 13F holder table
AVENUE THERAPEUTICS, INC. SEC filings
AVENUE THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of ATXI - AVENUE THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
8/15
Latest evidence
02 Dec 2024
13F
13D/G
3/4/5
Lead comparable stake: 5%
7 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
SABBY MANAGEMENT, LLC
2%
Moss Adams Wealth Advisors LLC
0.34%
UBS Group AG
0.19%
Tower Research Capital LLC (TRC)
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
5%
from 13D/G
|
$286,350
115,000 shares
|
— | 30 Sep 2024 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
2%
|
$157,019
63,060 shares
|
— | 30 Sep 2024 |
| Moss Adams Wealth Advisors LLC |
13F
Company
|
0.34%
|
$27,390
11,000 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.19%
|
$15,296
6,143 shares
|
— | 30 Sep 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.05%
|
$4,333
1,740 shares
|
— | 30 Sep 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.02%
|
$1,397
561 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
192,628
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
8
Q4 2024 holders
7
Holder diff
-1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|